11th April 2026, Saturday

TechPharus

Latest Posts

HealthTech News

  • Expanding the fight against heart disease: Q&A with specialist who welcomes shift to more aggressive recommendations
    on April 11, 2026 at 6:00 pm

    U.S. medical organizations are looking to reduce deaths caused by heart disease, the nation’s No. 1 killer, with new guidelines that reframe prevention as a lifelong battle that begins with testing in childhood.

  • Shifts in cancer mortality: Place of living increasingly determines where historic drop in cancer mortality reaches
    on April 11, 2026 at 6:00 pm

    In 1991, the U.S. experienced a significant shift in cancer death rates, as, for the first time, deaths began a steady decline that continues to the present day. Researchers at Mississippi State’s Social Science Research Center, in partnership with scientists at Oak Ridge National Laboratory, examined this decline to identify where and who benefited the most from this dramatic improvement.

  • Experimental drug cuts Parkinson’s-linked protein up to 60% in early trial
    on April 11, 2026 at 5:00 pm

    An experimental drug designed to silence a gene strongly linked to Parkinson’s disease has shown encouraging effects in a first-in-human clinical trial, according to a study published in Nature Medicine. The drug, known as BIIB094, targets LRRK2, the most common genetic contributor to Parkinson’s disease; variants in LRRK2 are known to increase the risk of developing the neurodegenerative disorder, which affects nearly 10 million people worldwide.

  • Antidepressant unable to prevent chemotherapy-associated nerve damage
    on April 11, 2026 at 4:00 pm

    A randomized trial conducted by the Alliance for Clinical Trials in Oncology has found that duloxetine, a medication commonly used to treat chronic pain and psychiatric conditions, does not prevent nerve damage caused by chemotherapy in patients with colorectal cancer. The primary analysis of Alliance A221805 was published in JCO Oncology Advances

  • New biological marker of early-stage Alzheimer’s disease uncovered
    on April 11, 2026 at 4:00 pm

    Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and a decline in mental functions. These symptoms are known to arise from an abnormal buildup of proteins known as amyloid and tau, which can damage or gradually destroy neurons and the connections between them.